Infection of bone -most commonly S. aureus. Hematogenous in children, contiguous spread in adults (diabetic foot, decubitus ulcers, post-surgical). MRI is the imaging gold standard. Bone biopsy is the diagnostic gold standard. Treatment is 6 weeks of targeted antibiotics -oral step-down is non-inferior to IV (OVIVA 2019).
๐ Overview
Classification
Type
Mechanism
Typical Patient
Common Organisms
Hematogenous
Bacteremia seeds bone (metaphysis in children, vertebral body in adults)
Children, IVDU (vertebral), sickle cell disease
S. aureus (#1 overall). Salmonella in SCD. Pseudomonas in IVDU.
Contiguous spread
Direct extension from adjacent soft tissue infection, open fracture, or surgery
Chronic ischemia + minor trauma/ulceration โ infection spreads to bone
Diabetic foot, peripheral arterial disease
Polymicrobial: S. aureus, Streptococcus, Enterococcus, gram-negatives (E. coli, Proteus), anaerobes (Bacteroides).
Acute vs Chronic
Feature
Acute
Chronic
Duration
< 2 weeks of symptoms
> 6 weeks, or recurrent
Pathology
Suppurative infection, edema
Sequestrum (dead bone), involucrum (new bone around dead bone), sinus tracts
Treatment
Antibiotics often curative alone
Usually requires surgical debridement + prolonged antibiotics
Probe-to-bone test: In diabetic foot ulcers, if a sterile metal probe reaches bone through the ulcer, the positive predictive value for osteomyelitis is ~89%. Simple, bedside, no imaging needed.
๐จ Management
Antibiotic Duration
Standard: 6 weeks of targeted antibiotics. Oral step-down after initial IV is acceptable -OVIVA trial showed oral antibiotics were non-inferior to IV for bone and joint infections at 1 year OVIVA, 2019.
Spinal epidural abscess with neurological compromise -neurosurgical emergency
Diabetic foot with non-healing ulcer and extensive bony involvement -may need amputation
Do NOT start antibiotics before bone biopsy/cultures if the patient is stable. Pre-biopsy antibiotics reduce culture yield and may lead to months of unnecessarily broad therapy. Exception: septic or hemodynamically unstable patients -treat empirically, culture what you can.
๐งช Workup
Diagnostic Evaluation
ESR and CRP -elevated in >90% of cases. ESR >70 is highly suggestive. Use to monitor treatment response.
Blood cultures (ร2 sets) -positive in ~50% of hematogenous osteomyelitis. Always obtain before antibiotics.
CBC -WBC may be normal in chronic osteomyelitis. Left shift suggests acute infection.
Plain radiographs -first-line imaging. Changes take 10โ14 days to appear (periosteal reaction, lytic lesions). Normal X-ray does NOT rule out early osteomyelitis.
MRI with gadolinium -imaging gold standard. Sensitivity 90โ100%, specificity 80โ90%. Shows bone marrow edema, soft tissue extent, abscess.
Bone biopsy with culture -diagnostic gold standard. Identifies organism and sensitivities. Essential for targeted therapy. IR-guided or open surgical.
Probe-to-bone test -bedside test for diabetic foot ulcers. PPV ~89% if positive.
MRI cannot distinguish osteomyelitis from Charcot arthropathy in diabetic feet -both show bone marrow edema. Clinical correlation and biopsy are essential in this setting.
๐ Medications
Targeted Therapy (Based on Culture)
Organism
First-Line
Alternative
Duration / Notes
MSSA* *= Methicillin-Sensitive Staph aureus
Nafcillin (Nallpen) 2g IV q4h or Cefazolin (Ancef) 2g IV q8h
Oral step-down: Cephalexin (Keflex) 1g PO QID or Dicloxacillin (Dynapen) 500mg PO QID
6 weeks. IV ร 1โ2 weeks then oral step-down per OVIVA. Cefazolin preferred for ease of outpatient dosing (q8h vs q4h).
MRSA* *= Methicillin-Resistant Staph aureus
Vancomycin (Vancocin) 15โ20 mg/kg IV q8โ12h (target AUC/MIC 400โ600)
Oral step-down: TMP-SMX (Bactrim) DS 1โ2 tabs PO BID + Rifampin (Rifadin) 300mg PO BID
6 weeks. Rifampin for biofilm penetration (hardware infections). Never use rifampin monotherapy -resistance develops rapidly.
Streptococcus
Ceftriaxone (Rocephin) 2g IV daily
Penicillin G or Amoxicillin (Amoxil) 1g PO TID
6 weeks. Strep are reliably penicillin-sensitive.
Pseudomonas
Cefepime (Maxipime) 2g IV q8h or Piperacillin-tazobactam (Zosyn)
Ciprofloxacin (Cipro) 750mg PO BID (oral option with good bone penetration)
6 weeks. Cipro has excellent oral bioavailability and bone penetration -preferred oral agent for Pseudomonas osteo.
Salmonella (SCD)
Ceftriaxone (Rocephin) 2g IV daily
Ciprofloxacin (Cipro) 500mg PO BID
6 weeks. Most common cause of osteomyelitis in sickle cell disease.
6 weeks. Surgical debridement is almost always needed. Vascular assessment essential.
๐ On Rounds
Pimp Questions
What is the most common organism causing osteomyelitis overall? In sickle cell disease?
Overall: S. aureus -accounts for ~60% of all osteomyelitis. In sickle cell disease: Salmonella -infarcted bone from vaso-occlusive crises is a perfect growth medium. This is a classic boards distinction. However, S. aureus is still #1 for septic arthritis in SCD.
Why is bone biopsy considered the gold standard over blood cultures?
Blood cultures are positive in only ~50% of hematogenous osteomyelitis and even less in contiguous spread. Bone biopsy with culture identifies the exact organism and sensitivities, allowing targeted narrow-spectrum therapy for a 6-week course. Without culture data, you may commit a patient to 6 weeks of unnecessarily broad-spectrum antibiotics with more side effects, higher cost, and greater resistance risk.
Can you treat osteomyelitis with oral antibiotics?
Yes. The OVIVA trial (2019) randomized 1,054 patients with bone/joint infections to IV vs oral antibiotics after initial surgical management. Oral was non-inferior at 1 year (treatment failure 14.6% oral vs 14.1% IV). Key caveat: patients had a defined organism with known oral sensitivities, and oral agents with good bone penetration were used (fluoroquinolones, rifampin combinations, linezolid).
Why should you never use rifampin as monotherapy?
Rifampin has excellent biofilm penetration (critical for hardware-associated infections) and good bone penetration. However, resistance develops extremely rapidly with monotherapy -single-step mutations in the rpoB gene occur at a rate of ~10โปโธ, which is high enough to select resistant mutants within days. Always combine with another active agent (e.g., TMP-SMX, fluoroquinolone, vancomycin).
Clinical Examples
๐ Case 1, Vertebral Osteomyelitis from Bacteremia
Patient: 62M IVDU with 3 weeks of progressive back pain and low-grade fevers. MRI spine: L3-L4 vertebral body edema, disc enhancement, paravertebral phlegmon. Blood cultures: MSSA. No epidural abscess.
Key findings: Vertebral osteomyelitis (most common location for hematogenous osteomyelitis in adults). IVDU + S. aureus bacteremia. Must rule out epidural abscess (MRI with contrast is the gold standard). No surgical indication without abscess or instability.
Management:
Nafcillin 2g IV q4h ร 6 weeks (MSSA โ beta-lactam preferred over vancomycin for efficacy)
Add rifampin 300 mg PO BID after 2 weeks of IV therapy (enhances biofilm penetration, always in combination, never alone)
TTE โ if positive or high suspicion: TEE to rule out endocarditis (IVDU + S. aureus = 30% concurrent IE)
PICC line for outpatient IV antibiotics (OPAT) if clinically stable after initial improvement
Teaching point: Every case of vertebral osteomyelitis needs an MRI of the ENTIRE spine (multifocal in 10-15%) and evaluation for endocarditis (especially S. aureus). Blood cultures are positive in 50-60%, get them before antibiotics.
๐ Case 2, Diabetic Foot Osteomyelitis
Patient: 68M with T2DM (A1c 10.2), presents with non-healing plantar ulcer ร 3 months over 2nd metatarsal head. Ulcer depth: bone is palpable with sterile probe ("probe to bone" positive). XR: periosteal reaction and cortical erosion of 2nd metatarsal.
Key findings: Diabetic foot osteomyelitis, "probe to bone" test has 89% PPV for osteomyelitis when positive in a diabetic foot ulcer. X-ray changes confirm chronic osteomyelitis (periosteal reaction, cortical destruction).
Management:
MRI foot (best imaging) to delineate extent of bone involvement and surgical planning
Bone biopsy + culture before antibiotics if possible (wound swabs are unreliable, contaminated with skin flora)
Empiric: vancomycin + piperacillin-tazobactam (cover MRSA + GNR + anaerobes) โ narrow based on bone culture
Surgical debridement or limited amputation (ray amputation) for devitalized bone, antibiotics alone cannot cure dead bone
Offloading: total contact cast or removable walking boot (pressure relief is essential for healing)
Teaching point: Wound swab cultures do NOT reflect bone pathogens, bone biopsy is the gold standard for guiding antibiotic therapy. If bone is visible or palpable in a diabetic foot ulcer, treat as osteomyelitis. MRI is the best imaging modality (sensitivity 90%, specificity 80%).
Key findings: Chronic prosthetic joint infection (PJI), onset > 3 months post-op. CoNS is #1 organism in chronic PJI (biofilm former on prosthetic material). Synovial WBC > 3,000 with > 80% PMNs meets MSIS criteria for PJI in a prosthetic joint.
Management:
Two-stage exchange arthroplasty (gold standard for chronic PJI): remove prosthesis โ antibiotic spacer ร 6-8 weeks โ reimplant new prosthesis
IV vancomycin ร 6 weeks (CoNS, often methicillin-resistant) + rifampin 300 mg PO BID (biofilm penetration)
Alternative (select cases): DAIR (debridement, antibiotics, implant retention) if: < 3 weeks of symptoms, stable implant, susceptible organism
ID consult for antibiotic optimization and duration
Withhold reimplantation until CRP normalizes and repeat aspiration is negative
Teaching point: Rifampin is the key drug in prosthetic joint infections, it penetrates biofilms that other antibiotics cannot reach. But NEVER use rifampin alone (rapid resistance in days). Always combine with vancomycin, TMP-SMX, or a fluoroquinolone.
๐ฃ Sample Presentation
One-Liner
"Mrs. Garcia is a 62-year-old woman with poorly controlled diabetes (A1c 9.8%) and a non-healing right plantar ulcer ร 3 months, now with exposed bone on probing and MRI showing marrow edema in the 2nd metatarsal head consistent with osteomyelitis."
Key Points to Cover on Rounds
Diabetic foot ulcer with positive probe-to-bone. MRI confirms osteomyelitis of 2nd metatarsal head -no abscess, no soft tissue collection. ESR 88, CRP 6.4. Blood cultures ร 2 pending. IR-guided bone biopsy scheduled tomorrow -holding antibiotics until culture obtained (patient is hemodynamically stable). Vascular surgery consulted for ABI assessment -pedal pulses palpable. Podiatry involved for wound care. Plan: bone biopsy โ targeted antibiotics ร 6 weeks, oral step-down when organism and sensitivities known. Glucose management with insulin drip per endocrine.
Monitoring Parameters
ESR and CRP -check weekly. CRP normalizes faster (1โ2 weeks). ESR may take weeks to decline. Failure to trend down suggests treatment failure or undrained collection.
CBC with differential -weekly. Monitor WBC normalization.
Vancomycin levels -if on vancomycin, target AUC/MIC 400โ600. Check trough before 4th dose, then 1โ2ร weekly.
Renal function (BMP) -weekly if on vancomycin or aminoglycosides. Watch for nephrotoxicity.
LFTs -if on rifampin (hepatotoxic). Baseline then q2 weeks.
PICC line site -daily inspection for infection, thrombosis if on prolonged IV therapy.
Repeat imaging -not routine. Repeat MRI only if clinical concern for treatment failure or new collection. Imaging lags behind clinical improvement.
RoundsRx Licensed Content - Unauthorized Use Prohibitedโก Summary
Microbiology
S. aureus is #1 overall. Salmonella in SCD. Pseudomonas in IVDU. Polymicrobial in diabetic foot (staph + gram-negatives + anaerobes).
Diagnosis
MRI = imaging gold standard (sens 90โ100%). Bone biopsy with culture = diagnostic gold standard. Probe-to-bone test for diabetic foot (PPV ~89%). Plain films take 10โ14 days to show changes.
Treatment Duration
6 weeks of targeted antibiotics. Oral step-down is non-inferior to IV (OVIVA 2019). Hold antibiotics for biopsy if patient is stable.
MSSA / MRSA
MSSA: nafcillin or cefazolin โ oral cephalexin. MRSA: vancomycin โ oral TMP-SMX + rifampin. Never use rifampin monotherapy.
Surgical Indications
Chronic with sequestrum, failed medical therapy, hardware infection (implant removal), abscess drainage, spinal epidural abscess with neuro compromise.
Monitoring
ESR/CRP weekly (CRP normalizes faster). Vancomycin AUC/MIC if applicable. BMP for nephrotoxicity. Repeat MRI only if treatment failure suspected.